missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18529644

ILT7/CD85g/LILRA4 Antibody (656688), mFluor Violet 610 SE, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals FAB6287MFV610

Product Code. 18529644

  • £476.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

ILT7/CD85g/LILRA4 Monoclonal antibody specifically detects ILT7/CD85g/LILRA4 in Human samples. It is validated for Flow Cytometry, CyTOF
TRUSTED_SUSTAINABILITY
Specifications

Specifications

ILT7/CD85g/LILRA4
Monoclonal
mFluor Violet 610 SE
50mM Sodium Borate
Mouse
Protein A or G purified from hybridoma culture supernatant
RUO
23547
Store at 4C in the dark.
IgG2a
Flow Cytometry, CyTOF
656688
Flow Cytometry, CyTOF-ready
CD85 antigen-like family member G, CD85g, CD85g antigen, ILT-7, ILT7MGC129598, Immunoglobulin-like transcript 7, leukocyte immunoglobulin-like receptor subfamily A member 4, leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4, leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member4, MGC129597
Mouse myeloma cell line NS0-derived recombinant human LILRA4/CD85g/ILT7, Glu24-Asn446, Accession # P59901
0.1 mL
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.